The pilot study concluded with 20 patients completing the full protocol. While the sample size is small, the researchers found the data sufficiently compelling to justify larger, more comprehensive controlled trials. These future studies will be essential to determine if the Mediterranean diet can maintain its efficacy over longer periods and how it performs across a broader, more diverse population of IBS sufferers.
William Chey, M.D., the chief of Gastroenterology at the University of Michigan and senior author of the paper, emphasized the importance of expanding the toolkit available to clinicians and patients. Dr. Chey, who is also the president-elect of the American College of Gastroenterology, noted that the findings provide a new avenue for evidence-based care.
"This study adds to a growing body of evidence which suggests that a Mediterranean diet might be a useful addition to the menu of evidence-based dietary interventions for patients with IBS," Dr. Chey said.
The potential for the Mediterranean diet to serve as a "first-line" intervention is particularly intriguing to the research team. Because the low FODMAP diet is usually executed in three phases—restriction, reintroduction, and personalization—it can take months for a patient to identify their specific triggers and return to a more varied diet. The Mediterranean diet could potentially offer a simpler starting point that improves overall health while simultaneously addressing gastrointestinal distress.
Moving forward, the researchers believe that the next critical step is to compare the long-term efficacy of the Mediterranean diet with the long-term outcomes of patients who have completed all phases of the low FODMAP diet. Since the goal of any IBS treatment is to find the most liberal diet possible that still controls symptoms, understanding how these two approaches compare over six months or a year will be vital.
The study serves as a reminder that in the management of chronic conditions like IBS, "one size" rarely fits all. By proving that a less restrictive, heart-healthy diet can produce meaningful symptom relief in nearly three-quarters of patients, Michigan Medicine researchers have opened the door to a more holistic approach to digestive health—one that considers not just the absence of pain, but the overall well-being and lifestyle of the patient. As the medical community awaits larger trials, this pilot study provides a hopeful signal that the path to relief for IBS may be found in the diverse and nutrient-rich traditions of the Mediterranean table.
